This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Medical 21, Inc., University of Iowa Research Foundation. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Chaid D Schwarz: Innovator in Biodegradable Implants
Introduction
Chaid D Schwarz is a notable inventor based in Medina, MN (US), recognized for his contributions to the field of biomedical engineering. He holds 2 patents that focus on innovative solutions for tissue engineering and regenerative medicine.
Latest Patents
One of his latest patents is for a composite implant that features multiple open-pore biodegradable polymer layers. These layers are mechanically supported by a permanent structure positioned between adjacent polymer layers. This design drives a native response for cellular infiltration, facilitating progressive cellular-driven remodeling, cellular organization, and native extra-cellular matrix (ECM) deposition. Over time, this leads to endogenous tissue remodeling of the implant. The support structure provides mechanical support to effectively carry impressed mechanical loads while the remodeling process is ongoing. The polymer layers are formulated to fully degrade over time, leaving only the new native tissue supported by the permanent support structure.
Another significant patent involves methods of producing biosynthetic bacterial cellulose membranes. These membranes possess improved characteristics that are advantageous for various biological applications, including medicine.
Career Highlights
Chaid D Schwarz has worked with several organizations, including Medical 21, Inc. and the University of Iowa Research Foundation. His work has significantly impacted the development of innovative medical solutions.
Collaborations
He has collaborated with notable individuals in his field, including Eric E Solien and Manuel A Villafana.
Conclusion
Chaid D Schwarz is a pioneering inventor whose work in biodegradable implants and biosynthetic membranes is shaping the future of regenerative medicine. His contributions are vital for advancing medical technologies that improve patient outcomes.